In addition to chemical competitive inhibitors, anti-ATX DNA aptamers have also been designed, and the aptamer RB014 exhibits efficacy in a mouse bleomycin-induced model of pulmonary fibrosis [184]. This evidence concerns the gene ENPP2 and pulmonary fibrosis.